Vivian Bykerk, BSc, MD, from Hospital for Special Surgery, answers our questions on new research about the impact of HLA-DRB1 risk alleles on the clinical efficacy of 2 biologic agents for the...
Lead author Lihi Eder, MD, PhD, answers our questions about her study that evaluated musculoskeletal issues preceding patients’ diagnosis of psoriatic arthritis. This period may represent a window for...
Peter Mandl, MD, PhD, answers our questions about his research that shed light on the advantages and disadvantages of implementing imaging techniques into a treat-to-target approach in psoriatic arthritis...
Vanessa Kronzer, MD, from the Mayo Clinic, answers our questions about her study that assessed the association between rheumatoid arthritis, asthma, passive smoke exposure, and more.
William G. Dixon, MRCP, MSc, PhD, answers our questions about remote monitoring of RA and how it may improve the collection of patient-generated health data to benefit the overall management of RA.
Marita Cross, PhD, from the Institute of Bone and Joint Research at the University of Sydney, answers our questions about her research on the global burden of rheumatoid arthritis.
Kathleen Ryan, PhD, answered our questions about her study, which indicated that rapid scale-up of PrEP was possible without the consequence of reduced HIV testing among Australian gay, bisexual, and other...
Adam Ford, BS, and April Armstrong, MD, MPH, answer our questions about the role of diet in psoriatic disease and the importance of dietary recommendations for individuals with psoriasis and/or psoriatic...
More adults aged 65 years or older are experiencing severe traumatic brain injury (TBI), and results of a new study show that these patients’ risk of mortality and severe morbidity is high. Lead study...
